Trials / Unknown
UnknownNCT04194515
Gut Microbiota and Bile Acids in Type 2 Diabetes Mellitus
Gut Microbiota and Bile Acids Mediate the Clinical Benefits of Metformin and YH1 in Patients With Treatment-naïve Type 2 Diabetes Mellitus: A Pilot Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- Male
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will evaluate the stool microbiota, serum and fecal bile acid composition, and changes in blood glucose and lipid profile before and after one month of metformin or YH1 treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YH1 | YH1 treatment for one month |
| DRUG | metformin | metformin treatment for one month |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2019-12-11
- Last updated
- 2021-01-27
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04194515. Inclusion in this directory is not an endorsement.